Follow-up of patients receiving rituximab for diffuse large B cell lymphoma: an overview of systematic reviews-Reference-Cited by-同舟云学术

Follow-up of patients receiving rituximab for diffuse large B cell lymphoma: an overview of systematic reviews

Published:2013-06-10 Issue:11 Volume:92 Page:1451-1459
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Lindenmeyer Luciane Pereira,Hegele Vanessa,Caregnato Juliana Prohonoski,Wüst Diego,Grazziotin Luiza,Stoll Paula

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-013-1811-4.pdf

Reference36 articles.

1. Flowers CR, Sinha R, Vose JM (2010) Improving outcomes for patients with diffuse large B cell lymphoma. CA Cancer J Clin 60(6):393–408. doi: 10.3322/caac.20087

2. Cultrera JL, Dalia SM (2012) Diffuse large B cell lymphoma: current strategies and future directions. Cancer Control 19(3):204–213

3. Michallet AS, Lebras L, Coiffier B (2012) Maintenance therapy in diffuse large B cell lymphoma. Curr Opin Oncol 24(5):461–465. doi: 10.1097/CCO.0b013e3283562036

4. Bhat SA, Czuczman MS (2009) Novel antibodies in the treatment of non-Hodgkin's lymphoma. Neth J Med 67(8):10

5. Rituximab: Drug information (2012) Lexicomp. http://www.uptodate.com . Accessed 24 January 2012

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of combinatorial antibody therapies for diffuse large B cell lymphoma;Frontiers in Medicine;2022-10-24

2. Predictive Parameters of Febrile Neutropenia and Clinical Significance of G-CSF Receptor Signaling Pathway in the Development of Neutropenia During R-CHOP Chemotherapy with Prophylactic Pegfilgrastim in Patients with Diffuse Large B-Cell Lymphoma;Cancer Research and Treatment;2021-12-31

3. Complicaties van behandeling met biologicals;Bijblijven;2018-01-18

4. Rituximab maintenance therapy for patients with diffuse large B-cell lymphoma: A meta-analysis;PLOS ONE;2017-03-29

5. Role of Rituximab and Rituximab Biosimilars in Diffuse Large B-Cell Lymphoma;Clinical Lymphoma Myeloma and Leukemia;2016-04